Understanding country-specific development of immunization programs is essential for their successful implementation.
As part of assessing the market opportunity for a vaccine, it is crucial to understand how countries translate new evidence for vaccines into favorable vaccine recommendations and what country-specific concerns/constraints may impede access.
Our client, a leading vaccine company, was looking for help to assess the market opportunity and policy developments for a maternal immunization across different countries.
Our team conducted a comprehensive assessment of the value drivers and barriers that influence vaccine recommendations through validation of internal hypotheses with relevant country-specific stakeholders.
First, we identified the value drivers for markets that have recently recommended a vaccine program and assessed barriers to recommendations in markets that do not recommend maternal vaccination.
Second, we pressure-tested our understanding of the triggers of recommendation decision-making and timing of inclusion in future immunization programs through one-on-one interviews with ex-policy makers and physicians.
We provided strategic guidance to increase the likelihood of a favorable vaccine recommendation by national immunization bodies.
For each country, we developed a stakeholder map for vaccine recommendation decisions and identified critical triggers for positive and negative immunization recommendation outcomes.
お問い合わせ
サイモン・クチャーのエキスパートがいつでもご相談に応じます。お気軽にお問い合わせください。